BioCardia, Inc

NeuCyte, Inc. is an innovative biotechnology company based in Mountain View, CA, specializing in CNS drug discovery. With their proprietary SynFire technology, they have developed a highly functional in vitro platform for target identification and validation, efficacy testing, neurotoxicity assessment, and disease modeling, focusing on genetically defined neurological diseases such as Alzheimer's disease, ALS, Epilepsy, and Fragile X Syndrome. NeuCyte's mission is to accelerate and optimize CNS drug discovery by developing more predictive assays and platforms for phenotypic screening, addressing the high attrition rate of novel CNS drugs during clinical development. They utilize patient-derived and genetically engineered neural cell types to build unique cell-based assays for modeling neurological and neurodegenerative disorders, aiming to provide more biologically relevant models for studying functional links between targets and phenotypes.Generated from the website

Rare Disease Therapeutics Inc. (RDT) is America's first exclusively orphan drug company, specializing in the commercialization of treatments for rare diseases since 1991. With over 30 years of experience, RDT offers a unique blend of regulatory expertise, marketing strategies, and medical knowledge to bring life-saving therapies to patients with unmet medical needs. As a privately held organization, RDT distinguishes itself from larger pharmaceutical companies by swiftly addressing patient needs and navigating the complexities of FDA approval for orphan drugs. Through its range of commercialization services, RDT supports pharmaceutical companies in advancing their orphan drug development initiatives. Generated from the website

Convicure is a research-based company located in Cupertino, CA, dedicated to diagnosing, preventing, and curing COVID-19 related viral diseases. Their team of experts, including renowned scientists and professors, is actively researching various molecules to treat COVID-19 symptoms, developing a fragmented RNA-based diagnostic for the virus, and working on a conformational frozen liposomal vaccination to combat the spread of the coronavirus pandemic. Their mission is to contribute to the fight against the infectious disease by providing innovative solutions and supporting education in the field. Convicure's focus lies in understanding the transmission of the virus and developing effective treatments to alleviate respiratory flu-like symptoms and prevent severe cases that may lead to difficulty breathing or death.Generated from the website